体組成計市場 : 2029年までの世界予測

Body Composition Analyzers Market - Global Forecast to 2029

体組成計市場 : 製品(生体インピーダンス分析装置、DEXA、スキンフォールドキャリパー、ADP)、モダリティ(ポータブル、据え置き型)、用途(部位別、全身測定)、流通チャネル(電子商取引、オフライン)市場規模、シェア&動向 - 2029年までの世界予測
Body Composition Analyzers Market Size, Share & Trends by Products (Bioimpedance analyzers, DEXA, Skinfold Calipers, ADP), Modality (Portable, Stationary), Application (Segmental, Whole Body Measurement), Distribution Channel (E-commerce, Offline) - Global Forecasts to 2029
出版年月2024年6月
ページ数280
図表数408
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Report Overview

The body composition analyzers market is valued at an estimated USD 0.8 billion in 2024 and is projected to reach USD 1.2 billion by 2029 at a CAGR of 9.3% during the forecast period.

体組成計市場は、2024 年に 8 億米ドルと推定され、予測期間中に 9.3% の CAGR で 2029 年までに 12 億米ドルに達すると予測されています。

Body composition analyzers is widely used by hospitals & clinics, fitness and wellness centers, academic & research centers and home users. It is also used in monitoring and tailoring fitness programs based on individual body composition data. Emeriging markets such as Asia Pacific region offer lucrative growth opportunities for body composition analyzers market.

体組成計市場 : 2029年までの世界予測

“Bioimpedance analyzers segment accounted for the highest growth rate in the body composition analyzers market, by product, during the forecast period.”
The body composition analyzers market is bifurcated into bioimpedance analyzers, dual-energy X-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, and hydrostatic weighing equipment. Bioimpedance analyzers segment in the body composition analyzers market is experiencing substantial growth. Major factors driving the growth of this segment include continuous improvements in bioimpedance technology to enhance accuracy, reliability, and user-friendliness.

体組成計市場 : 2029年までの世界予測 ecosystem

“Fitness and wellness centers segment accounted for the highest growth rate in the body composition analyzers market, by end users, during the forecast period.”
The body composition analyzers market is bifurcated into into hospitals & clinics, fitness clubs and wellness centers, academic & research centers and home users. Fitness clubs and wellness centers use body composition analyzers to create personalized training and nutrition plans for clients, enhancing program effectiveness. These tailored approaches help optimize individual fitness outcomes and overall wellness.

“Asia Pacific: The fastest-growing region body composition analyzers market.”
The worldwide market for human identification is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region market is expected to register the highest growth rate during the forecast period, mainly due to the rapid urbanization and lifestyle changes, such as sedentary habits and poor diets, are driving demand for body composition analyzers in the region. These devices help address emerging health concerns by providing detailed insights into body composition which reflects the growing need for effective health management solutions.
The break-up of the profile of primary participants in the body composition analyzers market:

• By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35%
• By Designation: C-level – 30%, D-level – 20%, and Others – 50%
• By Region: North America – 36%, Europe – 25%, Asia Pacific – 27%, Rest of the World – 12%

体組成計市場 : 2029年までの世界予測 region

The key players in this market are Omron Corporation (Japan), Hologic Inc. (US), GE Healthcare (US), InBody Co., Ltd. (South Korea), Cosmed S.R.L (Italy), Seca GmbH & Co. KG (Germany), Osteosys Corp (South Korea), Tanita Corporation (Japan), Evolt (Australia), RJL Systems (US), Charder Electronic Co, Ltd. (Taiwan), Samco Medical (Pakistan), BioTekna (Italy), Selvas Healthcare (South Korea), Swissray International (US), Shanghai Goldenwell Medical Technology Co., Ltd. (China), Maltron Internation Ltd. (UK), Akern (Italy), Bioparhom (France), Exertech (US), Microlife Corporation (Switzerland), Numed S.A.R.L (Lebanon), Biodynamics Corporation (US), Tongfang Health Technology Co., Ltd. (China), Fook Tin Technologies Ltd. (Hongkong), and Withings (France).

Research Coverage:
This research report categorizes the body composition analyzers market by product (Bioimpedance Analyzers (Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzers), Dual-energy X-ray Absorptiometry Equipment, Skinfold Calipers, Air Displacement Plethysmography Equipment, and Hydrostatic Weighing Equipment), by modality (Portable Body Composition Analyzers, and Stationary/Benchtop Body Composition Analyzers), by usage type (Professional-Grade Body Composition Analyzers, and Consumer-Grade Body Composition Analyzers), by application (Segmental Body Measurement, and Whole-body Measurement), by distribution channel (e-commerce, and Offline/Retail Stores), by end users (Hospitals & Clinics, Fitness Clubs and Wellness Centers, Academic & Research Centers, and Home Users) and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the body composition analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the body composition analyzers market. Competitive analysis of upcoming startups in the body composition analyzers market ecosystem is covered in this report.

Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body composition analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Growing prevalence of obesity and subsequent rise in metabolic disorders, and supportive government initiatives for healthcare awareness), restraints (high cost of equipment and availability of alternative methods), opportunities (Increasing establishment of fitness clubs and healthcare centers, integration of wearable healthcare devices with bioimpedance analyzers, Increasing adoption of self-monitoring devices) and challenges (Accuracy concerns associated with analyzers, and limited awareness in emerging markets) influencing the growth of the body composition analyzers market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body composition analyzers market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the body composition analyzers market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body composition analyzers market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Omron Corporation (Japan), Hologic Inc. (US), and GE Healthcare (US).

Table of Contents

1            INTRODUCTION            44

1.1         STUDY OBJECTIVES      44

1.2         MARKET DEFINITION   44

1.3         INCLUSIONS AND EXCLUSIONS 45

TABLE 1             BODY COMPOSITION ANALYZERS MARKET: INCLUSIONS AND EXCLUSIONS    45

1.4         MARKET SCOPE             46

1.4.1      MARKET SEGMENTATION         46

FIGURE 1           BODY COMPOSITION ANALYZERS MARKET: MARKET SEGMENTS COVERED   46

1.4.2      REGIONAL SEGMENTATION     46

FIGURE 2           BODY COMPOSITION ANALYZERS MARKET: REGIONS COVERED          46

1.4.3      YEARS CONSIDERED     47

1.5         CURRENCY CONSIDERED          47

1.6         STAKEHOLDERS            47

1.7         SUMMARY OF CHANGES            48

1.7.1      RECESSION IMPACT      49

2            RESEARCH METHODOLOGY     50

2.1         RESEARCH DATA           50

FIGURE 3           BODY COMPOSITION ANALYZERS MARKET: RESEARCH DESIGN              50

2.1.1      SECONDARY DATA       51

2.1.1.1   Key data from secondary sources     52

2.1.2      PRIMARY DATA 53

2.1.2.1   Primary sources   53

2.1.2.2   Key industry insights          54

2.1.2.3   Key data from primary sources         54

2.1.2.4   Breakdown of primary interviews     55

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    55

2.2         MARKET SIZE ESTIMATION       56

2.2.1      BOTTOM-UP APPROACH           56

2.2.1.1   Approach 1: Company revenue estimation approach    57

FIGURE 5           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH       57

2.2.1.2   Approach 2: Presentations of companies and primary interviews              57

2.2.1.3   Approach 3: Demand-side analysis  57

2.2.1.4   Growth forecast   58

2.2.1.5   CAGR projections             58

FIGURE 6           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   58

2.2.2      TOP-DOWN APPROACH             59

FIGURE 7           BODY COMPOSITION ANALYZERS MARKET: TOP-DOWN APPROACH       59

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          60

FIGURE 8           DATA TRIANGULATION METHODOLOGY         60

2.4         MARKET SHARE             61

2.5         STUDY ASSUMPTIONS  61

FIGURE 9           BODY COMPOSITION ANALYZERS MARKET: STUDY ASSUMPTIONS 61

2.6         RESEARCH LIMITATIONS           62

2.7         RISK ASSESSMENT         62

TABLE 2             BODY COMPOSITION ANALYZERS MARKET: RISK ASSESSMENT ANALYSIS          62

2.8         RECESSION IMPACT ANALYSIS 63

3            EXECUTIVE SUMMARY 64

FIGURE 10         BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)     64

FIGURE 11         BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024 VS. 2029 (USD MILLION)     65

FIGURE 12         BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024 VS. 2029 (USD MILLION)     65

FIGURE 13         BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)     66

FIGURE 14         BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)            67

FIGURE 15         BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)     67

FIGURE 16         BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)             68

4            PREMIUM INSIGHTS      69

4.1         BODY COMPOSITION ANALYZERS MARKET OVERVIEW 69

FIGURE 17         RISING PREVALENCE OF OBESITY AND SUBSEQUENT RISE IN METABOLIC DISORDERS TO DRIVE MARKET    69

4.2         BODY COMPOSITION ANALYZERS MARKET, BY REGION             69

FIGURE 18         BIOIMPEDANCE ANALYZERS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 69

4.3         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2023)           70

FIGURE 19         BIOIMPEDANCE ANALYZERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023          70

4.4         GEOGRAPHIC GROWTH OPPORTUNITIES         71

FIGURE 20         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD       71

5            MARKET OVERVIEW     72

5.1         INTRODUCTION            72

5.2         MARKET DYNAMICS     72

FIGURE 21         BODY COMPOSITION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       72

5.2.1      DRIVERS            73

5.2.1.1   Growing prevalence of obesity and subsequent rise in metabolic disorders              73

5.2.1.2   Supportive government initiatives for healthcare awareness       73

5.2.2      RESTRAINTS     74

5.2.2.1   High cost of equipment      74

5.2.2.2   Availability of alternative products   74

5.2.3      OPPORTUNITIES           74

5.2.3.1   Increasing establishment of fitness clubs and healthcare centers 74

5.2.3.2   Integration of wearable healthcare devices with bioimpedance analyzers  74

5.2.3.3   Growing adoption of self-monitoring devices 75

5.2.4      CHALLENGES   75

5.2.4.1   Accuracy concerns associated with analyzers  75

5.2.4.2   Limited awareness in emerging markets         75

5.3         PRICING ANALYSIS        76

5.3.1      AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION              76

5.3.2      AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE  77

5.4         VALUE CHAIN ANALYSIS            78

FIGURE 22         BODY COMPOSITION ANALYZERS MARKET: VALUE CHAIN ANALYSIS          78

5.5         SUPPLY CHAIN ANALYSIS          79

FIGURE 23         BODY COMPOSITION ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS          79

5.6         PORTER’S FIVE FORCES ANALYSIS         80

TABLE 3             BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS         80

FIGURE 24         BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS         80

5.6.1      INTENSITY OF COMPETITIVE RIVALRY 81

5.6.2      BARGAINING POWER OF SUPPLIERS     81

5.6.3      BARGAINING POWER OF BUYERS           81

5.6.4      THREAT OF NEW ENTRANTS    81

5.6.5      THREAT OF SUBSTITUTES         81

5.7         ECOSYSTEM ANALYSIS 81

FIGURE 25         BODY COMPOSITION ANALYZERS MARKET: ECOSYSTEM MARKET/MAP  82

5.7.1      BODY COMPOSITION ANALYZERS MARKET: ROLE IN ECOSYSTEM              82

5.8         REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          83

TABLE 4             LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83

5.9         REGULATORY ANALYSIS            84

5.9.1      NORTH AMERICA          84

5.9.1.1   US         84

TABLE 5             US FDA: MEDICAL DEVICE CLASSIFICATION     84

5.9.1.2   Canada  84

TABLE 6             CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS          84

5.9.2      EUROPE             85

5.9.3      ASIA PACIFIC    85

5.9.3.1   Japan     85

TABLE 7             JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA              86

5.9.3.2   China     86

TABLE 8             CHINA: CLASSIFICATION OF MEDICAL DEVICES             86

5.9.3.3   India      87

5.10       PATENT ANALYSIS        88

5.11       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 89

FIGURE 26         REVENUE SHIFT IN BODY COMPOSITION ANALYZERS MARKET              89

5.12       KEY CONFERENCES & EVENTS, 2024−2025         89

TABLE 9             BODY COMPOSITION ANALYZERS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024−2025           89

5.13       TECHNOLOGY ANALYSIS           91

5.13.1    KEY TECHNOLOGIES    91

5.13.1.1 Bioimpedance analyzers market       91

5.13.2    ADJACENT TECHNOLOGIES      91

5.13.2.1 Dual-energy X-ray absorptiometry  91

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          92

5.14.1    KEY STAKEHOLDERS ON BUYING PROCESS       92

FIGURE 27         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY COMPOSITION ANALYZER PRODUCTS   92

TABLE 10           INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF BODY COMPOSITION ANALYZERS PRODUCTS (%)        92

5.14.2    BUYING CRITERIA         93

FIGURE 28         KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZER PRODUCTS       93

TABLE 11           KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZER PRODUCTS       93

5.15       TRADE ANALYSIS          93

TABLE 12           IMPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)     93

TABLE 13           EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)     94

5.16       INVESTMENT AND FUNDING SCENARIO            94

FIGURE 29         INVESTMENT AND FUNDING SCENARIO FOR KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET (2018−2023)            94

5.17       IMPACT OF GENERATIVE AI ON BODY COMPOSITION ANALYZERS MARKET            95

6            BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT         96

6.1         INTRODUCTION            97

TABLE 14           BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          97

6.2         BIOIMPEDANCE ANALYZERS    97

TABLE 15           BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 98

TABLE 16           BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 98

TABLE 17           NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    99

TABLE 18           EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          99

TABLE 19           ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    99

TABLE 20           LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    100

TABLE 21           GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    100

6.2.1      MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS          100

6.2.1.1   High accuracy and precision to boost demand 100

TABLE 22           MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY KEY PLAYER 101

TABLE 23           MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)       101

TABLE 24           NORTH AMERICA: MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102

TABLE 25           EUROPE: MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         102

TABLE 26           ASIA PACIFIC: MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102

TABLE 27           LATIN AMERICA: MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 103

TABLE 28           GCC COUNTRIES: MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 103

6.2.2      SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS        103

6.2.2.1   Low cost and easy accessibility to fuel market 103

TABLE 29           SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)  104

TABLE 30           NORTH AMERICA: SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104

TABLE 31           EUROPE: SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         104

TABLE 32           ASIA PACIFIC: SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105

TABLE 33           LATIN AMERICA: SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105

TABLE 34           GCC COUNTRIES: SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105

6.2.3      DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS           106

6.2.3.1   Advanced clinical & research capabilities to support market growth         106

TABLE 35           DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY KEY PLAYER     106

TABLE 36           DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)       106

TABLE 37           NORTH AMERICA: DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107

TABLE 38           EUROPE: DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         107

TABLE 39           ASIA PACIFIC: DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107

TABLE 40           LATIN AMERICA: DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108

TABLE 41           GCC COUNTRIES: DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108

6.3         DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT 108

6.3.1      ABILITY TO MEASURE BONE MINERAL DENSITY TO DRIVE MARKET              108

TABLE 42           DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)            109

TABLE 43           NORTH AMERICA: DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             109

TABLE 44           EUROPE: DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             110

TABLE 45           ASIA PACIFIC: DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             110

TABLE 46           LATIN AMERICA: DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             110

TABLE 47           GCC COUNTRIES: DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             111

6.4         SKINFOLD CALIPERS    111

6.4.1      EQUIPMENT MEASURES BODY FAT AND SKIN THICKNESS         111

TABLE 48           SKINFOLD CALIPERS MARKET, BY REGION, 2022–2029 (USD MILLION)          111

TABLE 49           NORTH AMERICA: SKINFOLD CALIPERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    112

TABLE 50           EUROPE: SKINFOLD CALIPERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     112

TABLE 51           ASIA PACIFIC: SKINFOLD CALIPERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          112

TABLE 52           LATIN AMERICA: SKINFOLD CALIPERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          113

TABLE 53          GCC COUNTRIES: SKINFOLD CALIPERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          113

6.5         AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT             113

6.5.1      RAPID RESULTS AND HIGH UPTAKE IN HEALTHCARE FACILITIES TO DRIVE MARKET 113

TABLE 54           AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)            114

TABLE 55           NORTH AMERICA: AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             114

TABLE 56           EUROPE: AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             114

TABLE 57           ASIA PACIFIC: AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             115

TABLE 58           LATIN AMERICA: AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             115

TABLE 59           GCC COUNTRIES: AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             115

6.6         HYDROSTATIC WEIGHING EQUIPMENT             116

6.6.1      HIGH MAINTENANCE AND LONG TESTING TIMES TO RESTRAIN MARKET            116

TABLE 60           HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          116

TABLE 61           NORTH AMERICA: HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         116

TABLE 62           EUROPE: HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    117

TABLE 63           ASIA PACIFIC: HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         117

TABLE 64           LATIN AMERICA: HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         117

TABLE 65           GCC COUNTRIES: HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         118

7            BODY COMPOSITION ANALYZERS MARKET, BY MODALITY       119

7.1         INTRODUCTION            120

TABLE 66           BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          120

7.2         PORTABLE BODY COMPOSITION ANALYZERS  120

7.2.1      REAL-TIME DATA TRANSMISSION AND ENHANCED CONNECTIVITY TO PROPEL MARKET    120

TABLE 67           PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)       121

TABLE 68           NORTH AMERICA PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121

TABLE 69           EUROPE PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         121

TABLE 70           ASIA PACIFIC PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 71           LATIN AMERICA PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 72           GCC COUNTRIES: PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122

7.3         STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS    123

7.3.1      MINIMAL REQUIREMENTS AND LOW MAINTENANCE TO BOOST DEMAND           123

TABLE 73           STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)            123

TABLE 74           NORTH AMERICA: STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              123

TABLE 75           EUROPE: STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124

TABLE 76           ASIA PACIFIC: STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124

TABLE 77           LATIN AMERICA: STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              124

TABLE 78           GCC COUNTRIES: STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              125

8            BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE    126

8.1         INTRODUCTION            127

TABLE 79           BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)          127

8.2         PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS        127

8.2.1      RISING ESTABLISHMENT OF WELLNESS & FITNESS CENTERS TO BOOST DEMAND           127

TABLE 80           PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)            128

TABLE 81           NORTH AMERICA: PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              128

TABLE 82           EUROPE: PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129

TABLE 83           ASIA PACIFIC: PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129

TABLE 84           LATIN AMERICA: PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              129

TABLE 85           GCC COUNTRIES: PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              130

8.3         CONSUMER-GRADE BODY COMPOSITION ANALYZERS 130

8.3.1      RISING TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH          130

TABLE 86           CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)            131

TABLE 87           NORTH AMERICA: CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131

TABLE 88           EUROPE: CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131

TABLE 89           ASIA PACIFIC: CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132

TABLE 90           LATIN AMERICA: CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132

TABLE 91           GCC COUNTRIES: CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132

9            BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION  133

9.1         INTRODUCTION            134

TABLE 92           BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          134

9.2         SEGMENTAL BODY MEASUREMENT      134

9.2.1      ABILITY TO IDENTIFY MUSCLE IMBALANCES AND ENABLE PERSONALIZED TRAINING TO BOOST DEMAND            134

TABLE 93           SEGMENTAL BODY MEASUREMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          135

TABLE 94           NORTH AMERICA: SEGMENTAL BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         135

TABLE 95           EUROPE: SEGMENTAL BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    135

TABLE 96           ASIA PACIFIC: SEGMENTAL BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 97          LATIN AMERICA: SEGMENTAL BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 98           GCC COUNTRIES: SEGMENTAL BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         136

9.3         WHOLE-BODY MEASUREMENT 137

9.3.1      GROWING UPTAKE OF DEXA AND BIOIMPEDANCE ANALYZERS TO DRIVE MARKET 137

TABLE 99           WHOLE-BODY MEASUREMENT MARKET, BY REGION, 2022–2029 (USD MILLION)     137

TABLE 100         NORTH AMERICA: WHOLE-BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    137

TABLE 101         EUROPE: WHOLE-BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    138

TABLE 102         ASIA PACIFIC: WHOLE-BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    138

TABLE 103         LATIN AMERICA: WHOLE-BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    138

TABLE 104         GCC COUNTRIES: WHOLE-BODY MEASUREMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    139

10          BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL         140

10.1       INTRODUCTION            141

TABLE 105         BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    141

10.2       OFFLINE/RETAIL STORES          141

10.2.1    BENEFITS INCLUDE CONVENIENCE AND ACCESSIBILITY           141

TABLE 106         OFFLINE/RETAIL STORES MARKET, BY REGION, 2022–2029 (USD MILLION) 141

TABLE 107         NORTH AMERICA: OFFLINE/RETAIL STORES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    142

TABLE 108         EUROPE: OFFLINE/RETAIL STORES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          142

TABLE 109         ASIA PACIFIC: OFFLINE/RETAIL STORES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    142

TABLE 110         LATIN AMERICA: OFFLINE/RETAIL STORES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    143

TABLE 111         GCC COUNTRIES: OFFLINE/RETAIL STORES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    143

10.3       E-COMMERCE  143

10.3.1    GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET 143

TABLE 112         E-COMMERCE MARKET, BY REGION, 2022–2029 (USD MILLION)              144

TABLE 113         NORTH AMERICA: E-COMMERCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          144

TABLE 114         EUROPE: E-COMMERCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144

TABLE 115         ASIA PACIFIC: E-COMMERCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145

TABLE 116         LATIN AMERICA: E-COMMERCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     145

TABLE 117         GCC COUNTRIES: E-COMMERCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     145

11          BODY COMPOSITION ANALYZERS MARKET, BY END USER         146

11.1       INTRODUCTION            147

TABLE 118         BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)          147

11.2       FITNESS CLUBS AND WELLNESS CENTERS         147

11.2.1    GROWING AWARENESS OF ACTIVE LIFESTYLES TO BOOST DEMAND              147

TABLE 119         BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2022–2029 (USD MILLION)              148

TABLE 120         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          148

TABLE 121         EUROPE: BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          148

TABLE 122         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          149

TABLE 123         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          149

TABLE 124         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          149

11.3       HOSPITALS AND CLINICS          150

11.3.1    GROWING UPTAKE OF DEXA IN OSTEOPOROSIS DETECTION TO BOOST DEMAND           150

TABLE 125         BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022–2029 (USD MILLION)    150

TABLE 126         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)              151

TABLE 127         EUROPE: BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)       151

TABLE 128         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)       151

TABLE 129         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)              152

TABLE 130         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)              152

11.4       ACADEMIC & RESEARCH CENTERS        152

11.4.1    RISING GRANTS AND FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH          152

TABLE 131         BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2022–2029 (USD MILLION)     153

TABLE 132         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          153

TABLE 133         EUROPE: BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              153

TABLE 134         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              154

TABLE 135         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          154

TABLE 136         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          154

11.5       HOME USERS    155

11.5.1    GROWING UPTAKE OF PORTABLE ANALYZERS TO DRIVE MARKET              155

TABLE 137         BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY REGION, 2022–2029 (USD MILLION)  155

TABLE 138         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2022–2029 (USD MILLION)      155

TABLE 139         EUROPE: BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2022–2029 (USD MILLION) 156

TABLE 140         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2022–2029 (USD MILLION) 156

TABLE 141         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2022–2029 (USD MILLION)      156

TABLE 142         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2022–2029 (USD MILLION)      157

12          BODY COMPOSITION ANALYZERS MARKET, BY REGION             158

12.1       INTRODUCTION            159

TABLE 143         BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)     159

12.2       NORTH AMERICA          159

12.2.1    NORTH AMERICA: RECESSION IMPACT 160

FIGURE 30         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT        160

TABLE 144         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            161

TABLE 145         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            161

TABLE 146         NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             161

TABLE 147         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          162

TABLE 148         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)        162

TABLE 149         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     162

TABLE 150         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            163

TABLE 151         NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)            163

12.2.2    US         163

12.2.2.1 Increasing prevalence of diabetes and CVD to drive market       163

TABLE 152         US: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          164

TABLE 153         US: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 164

TABLE 154        US: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          165

TABLE 155         US: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             165

TABLE 156         US: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           165

TABLE 157         US: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    166

TABLE 158         US: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)          166

TABLE 159         US: BODY COMPOSITION ANALYZERS MARKET FOR BIOIMPEDANCE ANALYZERS, BY END USER, 2022–2029 (UNITS) 166

12.2.3    CANADA            167

12.2.3.1 High prevalence of obesity to support market growth   167

TABLE 160         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   167

TABLE 161         CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          168

TABLE 162         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  168

TABLE 163         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             168

TABLE 164         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           169

TABLE 165         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    169

TABLE 166         CANADA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             169

12.3       EUROPE             170

12.3.1    EUROPE: RECESSION IMPACT   170

TABLE 167         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    170

TABLE 168         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   171

TABLE 169         EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          171

TABLE 170         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  172

TABLE 171         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             172

TABLE 172         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           172

TABLE 173         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    173

TABLE 174         EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             173

12.3.2    GERMANY         173

12.3.2.1 High healthcare expenditure to drive market  173

TABLE 175         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   174

TABLE 176         GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          174

TABLE 177         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  175

TABLE 178         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             175

TABLE 179         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           175

TABLE 180         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    176

TABLE 181         GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)    176

12.3.3    FRANCE             176

12.3.3.1 Growing uptake of bioimpedance analyzers to boost demand     176

TABLE 182         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   177

TABLE 183         FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          177

TABLE 184         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  178

TABLE 185         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             178

TABLE 186         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           178

TABLE 187         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    179

TABLE 188         FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             179

12.3.4    UK         179

12.3.4.1 Growing incidence of CKD to drive market    179

TABLE 189         UK: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          180

TABLE 190         UK: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 180

TABLE 191        UK: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          180

TABLE 192         UK: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             181

TABLE 193         UK: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           181

TABLE 194         UK: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    181

TABLE 195         UK: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)          182

12.3.5    ITALY   182

12.3.5.1 Growing demand for diagnostic & monitoring devices to drive market     182

TABLE 196         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   183

TABLE 197         ITALY: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     183

TABLE 198         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  184

TABLE 199         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             184

TABLE 200         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           184

TABLE 201         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    185

TABLE 202         ITALY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             185

12.3.6    SPAIN   185

12.3.6.1 Increasing cases of osteoporosis to support market growth         185

TABLE 203         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   186

TABLE 204         SPAIN: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     186

TABLE 205         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  187

TABLE 206         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             187

TABLE 207         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           187

TABLE 208         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    188

TABLE 209         SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             188

12.3.7    REST OF EUROPE           188

TABLE 210         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            189

TABLE 211         REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             189

TABLE 212         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          190

TABLE 213         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)        190

TABLE 214         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     190

TABLE 215         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            191

TABLE 216         REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)            191

12.4       ASIA PACIFIC    191

12.4.1    ASIA PACIFIC: RECESSION IMPACT        192

FIGURE 31         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT        193

TABLE 217         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    194

TABLE 218         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   194

TABLE 219         ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          195

TABLE 220         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  195

TABLE 221         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             195

TABLE 222         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           196

TABLE 223         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    196

TABLE 224         ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)    196

12.4.2    JAPAN  197

12.4.2.1 Supportive government initiatives and universal reimbursement coverage to boost demand 197

TABLE 225         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   197

TABLE 226         JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     198

TABLE 227         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  198

TABLE 228         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             198

TABLE 229         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           199

TABLE 230         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    199

TABLE 231         JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             199

12.4.3    CHINA  200

12.4.3.1 Rising cases of obesity in children to propel market      200

TABLE 232         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   200

TABLE 233         CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     201

TABLE 234         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  201

TABLE 235         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             201

TABLE 236         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           202

TABLE 237         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    202

TABLE 238         CHINA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             202

12.4.4    INDIA   203

12.4.4.1 Growing awareness of nutrition and healthcare to boost demand             203

TABLE 239         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   203

TABLE 240         INDIA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     203

TABLE 241         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  204

TABLE 242         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             204

TABLE 243         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           204

TABLE 244         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    205

TABLE 245         INDIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             205

12.4.5    REST OF ASIA PACIFIC  205

TABLE 246         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        206

TABLE 247         REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       206

TABLE 248         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)       207

TABLE 249         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)    207

TABLE 250         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  207

TABLE 251         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)         208

TABLE 252         REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)         208

12.5       LATIN AMERICA             208

12.5.1    LATIN AMERICA: RECESSION IMPACT   208

TABLE 253         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            209

TABLE 254         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            209

TABLE 255         LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             210

TABLE 256         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          210

TABLE 257         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)        210

TABLE 258         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     211

TABLE 259         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            211

TABLE 260         LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)            211

12.5.2    BRAZIL 212

12.5.2.1 Stringent regulatory requirements to boost demand     212

TABLE 261         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   212

TABLE 262         BRAZIL: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)     213

TABLE 263         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  213

TABLE 264         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             213

TABLE 265         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           214

TABLE 266         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    214

TABLE 267         BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             214

12.5.3    MEXICO             215

12.5.3.1 Increasing healthcare expenditure to support market growth      215

TABLE 268         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   215

TABLE 269         MEXICO: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          216

TABLE 270         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)  216

TABLE 271         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)             216

TABLE 272         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           217

TABLE 273         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)    217

TABLE 274         MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)             217

12.5.4    REST OF LATIN AMERICA          218

TABLE 275         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        218

TABLE 276         REST OF LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    219

TABLE 277         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)       219

TABLE 278         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)    219

TABLE 279         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  220

TABLE 280         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)         220

TABLE 281         REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)         220

12.6       MIDDLE EAST & AFRICA             221

12.6.1    LOW AVAILABILITY OF ADVANCED ANALYZERS TO RESTRAIN MARKET            221

12.6.2    MIDDLE EAST & AFRICA: RECESSION IMPACT   221

TABLE 282         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        221

TABLE 283         MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    222

TABLE 284         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)       222

TABLE 285         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)    222

TABLE 286         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  223

TABLE 287         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)         223

TABLE 288         MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)         223

12.7       GCC COUNTRIES           224

12.7.1    GCC COUNTRIES: RECESSION IMPACT 224

TABLE 289         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            224

TABLE 290         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            225

TABLE 291         GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             225

TABLE 292         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)          226

TABLE 293         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)        226

TABLE 294         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     226

TABLE 295         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            227

TABLE 296         GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)            227

12.7.2    KINGDOM OF SAUDI ARABIA (KSA)       227

12.7.2.1 increasing focus on preventive care to boost demand   227

TABLE 297         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 228

TABLE 298         KINGDOM OF SAUDI ARABIA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    228

TABLE 299         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)             229

TABLE 300         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)          229

TABLE 301         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)        229

TABLE 302         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)              230

TABLE 303         KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION) 230

12.7.3    UNITED ARAB EMIRATES (UAE)             230

12.7.3.1 Surge in fitness clubs to support market growth           230

TABLE 304         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        231

TABLE 305         UNITED ARAB EMIRATES: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    231

TABLE 306         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)       232

TABLE 307         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)    232

TABLE 308         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  232

TABLE 309         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)         233

TABLE 310         UNITED ARAB EMIRATES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)         233

12.7.4    OTHER GCC COUNTRIES           233

TABLE 311         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        234

TABLE 312         OTHER GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    234

TABLE 313         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2022–2029 (USD MILLION)       235

TABLE 314         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)    235

TABLE 315         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  235

TABLE 316         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)         236

TABLE 317         OTHER GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2022–2029 (USD MILLION)         236

13          COMPETITIVE LANDSCAPE       237

13.1       OVERVIEW        237

13.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          237

13.2.1    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET    237

TABLE 318         OVERVIEW OF STRATEGIES ADOPTED BY KEY BODY COMPOSITION ANALYZER MANUFACTURING COMPANIES       237

13.3       REVENUE ANALYSIS      238

FIGURE 32         REVENUE ANALYSIS OF KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET, 2021−2023 (USD MILLION)           238

13.4       MARKET SHARE ANALYSIS         239

FIGURE 33         MARKET SHARE ANALYSIS OF KEY PLAYERS IN BODY COMPOSITION MARKET (2023) 239

TABLE 319         BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 239

13.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   240

13.5.1    STARS  240

13.5.2    EMERGING LEADERS    240

13.5.3    PERVASIVE PLAYERS     240

13.5.4    PARTICIPANTS 241

FIGURE 34         BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      241

13.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      242

13.5.5.1 Company footprint            242

FIGURE 35         BODY COMPOSITION ANALYZERS MARKET: COMPANY FOOTPRINT      242

13.5.5.2 Product footprint 243

TABLE 320         BODY COMPOSITION ANALYZERS MARKET: PRODUCT FOOTPRINT      243

13.5.5.3 Modality footprint             243

TABLE 321         BODY COMPOSITION ANALYZERS MARKET: MODALITY FOOTPRINT      243

13.5.5.4 Application footprint         244

TABLE 322         BODY COMPOSITION ANALYZERS MARKET: APPLICATION FOOTPRINT      244

13.5.5.5 Region footprint  244

TABLE 323         BODY COMPOSITION ANALYZERS MARKET: REGION FOOTPRINT      244

13.6       COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023         245

13.6.1    PROGRESSIVE COMPANIES       245

13.6.2    RESPONSIVE COMPANIES          245

13.6.3    DYNAMIC COMPANIES 245

13.6.4    STARTING BLOCKS       245

FIGURE 36         BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023             246

13.6.5    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023           247

TABLE 324         BODY COMPOSITION ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SME PLAYERS         247

TABLE 325         BODY COMPOSITION ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES      248

13.7       VALUATION AND FINANCIAL METRICS 249

FIGURE 37         EV/EBITDA OF KEY VENDORS   249

FIGURE 38         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 249

13.8       BRAND/PRODUCT COMPARISON          250

FIGURE 39         DEXA SYSTEMS: BRAND/PRODUCT COMPARATIVE ANALYSIS              250

13.9       COMPETITIVE SCENARIO          250

13.9.1    DEALS  250

TABLE 326         BODY COMPOSITION ANALYZERS MARKET: DEALS, JANUARY 2021–MAY 2024 250

13.9.2    EXPANSIONS    251

TABLE 327         BODY COMPOSITION ANALYZERS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024            251

14          COMPANY PROFILES    252

14.1       KEY PLAYERS   252

(Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats)*

14.1.1    OMRON CORPORATION             252

TABLE 328         OMRON CORPORATION: COMPANY OVERVIEW             252

FIGURE 40         OMRON CORPORATION: COMPANY SNAPSHOT (2023) 253

TABLE 329         OMRON CORPORATION: PRODUCTS OFFERED 253

TABLE 330         OMRON CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2024      254

14.1.2    HOLOGIC, INC. 255

TABLE 331         HOLOGIC, INC.: COMPANY OVERVIEW 255

FIGURE 41         HOLOGIC, INC.: COMPANY SNAPSHOT (2023)   256

TABLE 332         HOLOGIC, INC.: PRODUCTS OFFERED  256

14.1.3    GE HEALTHCARE          258

TABLE 333         GE HEALTHCARE: COMPANY OVERVIEW           258

FIGURE 42         GE HEALTHCARE: COMPANY SNAPSHOT (2023)             259

TABLE 334         GE HEALTHCARE: PRODUCTS OFFERED            259

14.1.4    INBODY CO., LTD.         261

TABLE 335         INBODY CO., LTD.: COMPANY OVERVIEW          261

TABLE 336         INBODY CO., LTD.: PRODUCTS OFFERED           261

TABLE 337         INBODY CO., LTD.: DEALS, JANUARY 2021–MARCH 2024 262

14.1.5    RJL SYSTEMS    263

TABLE 338         RJL SYSTEMS: COMPANY OVERVIEW     263

TABLE 339         RJL SYSTEMS: PRODUCTS OFFERED      263

14.1.6    COSMED SRL    264

TABLE 340         COSMED SRL: COMPANY OVERVIEW     264

TABLE 341         COSMED SRL: PRODUCTS OFFERED      264

14.1.7    SECA GMBH & CO. KG.  265

TABLE 342         SECA GMBH & CO. KG: COMPANY OVERVIEW   265

TABLE 343         SECA GMBH & CO. KG: PRODUCTS OFFERED    265

14.1.8    TANITA CORPORATION             266

TABLE 344         TANITA CORPORATION: COMPANY OVERVIEW 266

TABLE 345         TANITA CORPORATION: PRODUCTS OFFERED 266

14.1.9    CHARDER ELECTRONIC CO, LTD.          268

TABLE 346         CHARDER ELECTRONIC CO. LTD.: COMPANY OVERVIEW              268

TABLE 347         CHARDER ELECTRONIC CO. LTD.: PRODUCTS OFFERED              268

14.1.10  SELVAS HEALTHCARE, INC.       269

TABLE 348         SELVAS HEALTHCARE: COMPANY OVERVIEW   269

TABLE 349         SELVAS HEALTHCARE: PRODUCTS OFFERED    269

14.1.11  EVOLT 270

TABLE 350         EVOLT: COMPANY OVERVIEW  270

TABLE 351         EVOLT: PRODUCTS OFFERED   270

*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.

14.2       OTHER PLAYERS           271

14.2.1    MALTRON INTERNATIONAL LTD.         271

TABLE 352         MALTRON INTERNATIONAL LTD.: COMPANY OVERVIEW              271

14.2.2    TONGFANG HEALTH TECHNOLOGY (BEIJING) CO., LTD.           272

TABLE 353         TONGFAND HEALTH TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW  272

14.2.3    BIOTEKNA        273

TABLE 354         BIOTEKNA: COMPANY OVERVIEW         273

14.2.4    FOOK TIN TECHNOLOGIES LTD.           274

TABLE 355         FOOK TIN TECHNOLOGIES LTD.: COMPANY OVERVIEW              274

14.2.5    BIODYNAMICS CORPORATION 275

TABLE 356         BIODYNAMICS CORPORATION: COMPANY OVERVIEW 275

14.2.6    BIOPARHOM     276

TABLE 357         BIOPARHOM: COMPANY OVERVIEW     276

14.2.7    MICROLIFE CORPORATION       277

TABLE 358         MICROLIFE CORPORATION: COMPANY OVERVIEW       277

14.2.8    NUMED S.A.R.L. 278

TABLE 359         NUMED S.A.R.L.: COMPANY OVERVIEW 278

14.2.9    SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.  279

TABLE 360         SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO. LTD.: COMPANY OVERVIEW  279

14.2.10  SAMCO MEDICAL          280

TABLE 361         SAMCO MEDICAL: COMPANY OVERVIEW           280

14.2.11  SWISSRAY          281

TABLE 362         SWISSRAY: COMPANY OVERVIEW          281

14.2.12  OSTEOSYS CORP.           282

TABLE 363         OSTEOSYS CORP.: COMPANY OVERVIEW           282

14.2.13  EXERTECH        283

TABLE 364         EXERTECH: COMPANY OVERVIEW         283

14.2.14  AKERN S.R.L      284

TABLE 365         AKERN S.R.L.: COMPANY OVERVIEW     284

14.2.15  WITHINGS         285

TABLE 366         WITHINGS: COMPANY OVERVIEW         285

15          APPENDIX         286

15.1       DISCUSSION GUIDE      286

15.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             291

15.3       CUSTOMIZATION OPTIONS      293

15.4       RELATED REPORTS       293

15.5       AUTHOR DETAILS         294